Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future - European Medical Journal

Please confirm the details below to continue

The content of this page has not been approved for distribution to United States and United Kingdom healthcare professionals or members of the public. If you are a UK healthcare professional and wish to find out more information, please find more information here www.health.novartis.co.uk

Continue

Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future

Oncology

Novartis sponsored ESMO 2021 Satellite Symposium: Navigating the Current Treatment Landscape

Faculty: Prof Eric Van Cutsem (Chair), Dr Elizabeth Smyth and Dr Lucjan Wyrwicz

Objectives:

  • Discuss the current patient journey and standards of care in esophageal cancer
  • Explore the current treatment landscape and latest data for the treatment of metastatic esophageal cancer in the first- and second-line setting
  • Discuss biomarkers and how they inform therapeutic decision-making in metastatic esophageal cancer
  • Identify the unmet needs of patients with esophageal cancer and how emerging immunotherapy regimens can potentially address these gaps

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.